Given the strong biochemical and cellular activity of Zharp1-163 as a RIPK1 kinase, we aimed to evaluate its therapeutic potential in a mouse model of TNF-induced SIRS [44, 45]. The gene discussed is TNF; the disease is systemic inflammatory response syndrome.